Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38 alpha Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3.
Ansideri, F., Macedo, J.T., Eitel, M., El-Gokha, A., Zinad, D.S., Scarpellini, C., Kudolo, M., Schollmeyer, D., Boeckler, F.M., Blaum, B.S., Laufer, S.A., Koch, P.(2018) ACS Omega 3: 7809-7831
- PubMed: 30087925 
- DOI: 10.1021/acsomega.8b00668
- Primary Citation of Related Structures:  
6EKD, 6EMH, 6EQ9 - PubMed Abstract: 
Starting from known p38α mitogen-activated protein kinase (MAPK) inhibitors, a series of inhibitors of the c-Jun N-terminal kinase (JNK) 3 was obtained. Altering the substitution pattern of the pyridinylimidazole scaffold proved to be effective in shifting the inhibitory activity from the original target p38α MAPK to the closely related JNK3 ...